| RS2514874118 |
SMARCA4
|
Health Risk |
Pathogenic |
Rhabdoid tumor predisposition syndrome 2, Rhabdoid tumor predisposition syndrome 2 |
| RS2514884822 |
SMARCA4
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2514886778 |
SMARCA4
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2514887105 |
SMARCA4
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2514890513 |
GZF1
|
Health Risk |
Pathogenic |
— |
| RS2514909662 |
DYM
|
Health Risk |
Likely pathogenic |
Dyggve-Melchior-Clausen syndrome, Dyggve-Melchior-Clausen syndrome |
| RS2514930352 |
CACNA1C
|
Health Risk |
Pathogenic |
— |
| RS2515003359 |
IL12RB1
|
Health Risk |
Pathogenic |
Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency, Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency |
| RS2515027089 |
SPTBN4
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with hypotonia, neuropathy |
| RS2515037913 |
MBOAT7
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal recessive 57 |
| RS2515039611 |
SPTBN4
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with hypotonia, neuropathy |
| RS2515045138 |
IL12RB1
|
Health Risk |
Pathogenic |
Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency, Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency |
| RS2515063089 |
SMARCA4
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2515069712 |
NAPB
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy-107, Developmental and epileptic encephalopathy-107 |
| RS2515114359 |
VPS16
|
Health Risk |
Likely pathogenic |
Dystonia 30, Dystonia 30 |
| RS2515115443 |
SMARCA4
|
Health Risk |
Pathogenic |
Rhabdoid tumor predisposition syndrome 2, Rhabdoid tumor predisposition syndrome 2 |
| RS2515118170 |
SMARCA4
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2515137975 |
VPS16
|
Health Risk |
Likely pathogenic |
Dystonia 30, Dystonia 30 |
| RS2515145626 |
MBOAT7
|
Health Risk |
Pathogenic |
— |
| RS2515170802 |
ACTN4
|
Health Risk |
Conflicting classifications of pathogenicity |
Focal segmental glomerulosclerosis 1, Focal segmental glomerulosclerosis 1 |
| RS2515172714 |
AHCY
|
Health Risk |
Pathogenic |
Hypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase, Hypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase |
| RS2515176041 |
SPTBN4
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with hypotonia, neuropathy |
| RS2515176184 |
AHCY
|
Health Risk |
Pathogenic |
Hypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase, Hypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase |
| RS2515178934 |
MBOAT7
|
Health Risk |
Likely pathogenic |
MBOAT7-related disorder, MBOAT7-related disorder |
| RS2515180222 |
AHCY
|
Health Risk |
Likely pathogenic |
Hypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase, Hypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase |
| RS2515181224 |
MBOAT7
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2515182138 |
PLCB1
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 12 |
| RS2515193918 |
ACTN4
|
Health Risk |
Pathogenic |
— |
| RS2515200645 |
ACTN4
|
Health Risk |
Likely pathogenic |
Focal segmental glomerulosclerosis 1, Focal segmental glomerulosclerosis 1 |
| RS2515200704 |
ACTN4
|
Health Risk |
Likely pathogenic |
ACTN4-related disorder, ACTN4-related disorder |
| RS2515200807 |
ACTN4
|
Health Risk |
Likely pathogenic |
Focal segmental glomerulosclerosis 1, Focal segmental glomerulosclerosis 1 |
| RS2515204157 |
THBD
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS2515204321 |
AHCY
|
Health Risk |
Pathogenic |
Hypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase, Hypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase |
| RS2515204417 |
SMARCA4
|
Health Risk |
Likely pathogenic |
Rhabdoid tumor predisposition syndrome 2, Rhabdoid tumor predisposition syndrome 2 |
| RS2515204602 |
ERGIC3
|
Health Risk |
Likely pathogenic |
Developmental disorder, Developmental disorder |
| RS2515208207 |
SMARCA4
|
Health Risk |
Pathogenic |
Rhabdoid tumor predisposition syndrome 2, Rhabdoid tumor predisposition syndrome 2 |
| RS2515210564 |
ACTN4
|
Health Risk |
Likely pathogenic |
ACTN4-related disorder, ACTN4-related disorder |
| RS2515216801 |
MGME1
|
Health Risk |
Pathogenic |
— |
| RS2515217064 |
SPTBN4
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with hypotonia, neuropathy |
| RS2515217377 |
SAMHD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Aicardi-Goutieres syndrome 5, Chilblain lupus 2 |
| RS2515217684 |
SAMHD1
|
Health Risk |
Pathogenic |
Aicardi-Goutieres syndrome 5, Aicardi-Goutieres syndrome 5 |
| RS2515217834 |
ACTN4
|
Health Risk |
Likely pathogenic |
Focal segmental glomerulosclerosis 1, Focal segmental glomerulosclerosis 1 |
| RS2515218976 |
SAMHD1
|
Health Risk |
Pathogenic |
Aicardi-Goutieres syndrome 5, Aicardi-Goutieres syndrome 5 |
| RS2515219038 |
SAMHD1
|
Health Risk |
Pathogenic |
Aicardi-Goutieres syndrome 5, Aicardi-Goutieres syndrome 5 |
| RS2515219215 |
SAMHD1
|
Health Risk |
Pathogenic |
Aicardi-Goutieres syndrome 5, Aicardi-Goutieres syndrome 5 |
| RS2515220138 |
RIN2
|
Health Risk |
Pathogenic |
— |
| RS2515221970 |
MGME1
|
Health Risk |
Pathogenic |
— |
| RS2515227348 |
SAMHD1
|
Health Risk |
Pathogenic |
Aicardi-Goutieres syndrome 5, Aicardi-Goutieres syndrome 5 |
| RS2515228923 |
SAMHD1
|
Health Risk |
Pathogenic |
Aicardi-Goutieres syndrome 5, Aicardi-Goutieres syndrome 5 |
| RS2515228997 |
SPTBN4
|
Health Risk |
Likely pathogenic |
SPTBN4-related disorder, SPTBN4-related disorder |
| RS2515229076 |
SAMHD1
|
Health Risk |
Likely pathogenic |
Aicardi Goutieres syndrome, Aicardi Goutieres syndrome |
| RS2515229165 |
SAMHD1
|
Health Risk |
Likely pathogenic |
Aicardi-Goutieres syndrome 5, Aicardi-Goutieres syndrome 5 |
| RS2515236081 |
SAMHD1
|
Health Risk |
Pathogenic |
Aicardi-Goutieres syndrome 5, Aicardi-Goutieres syndrome 5 |
| RS2515236164 |
SAMHD1
|
Health Risk |
Pathogenic |
Aicardi-Goutieres syndrome 5, Aicardi-Goutieres syndrome 5 |
| RS2515236180 |
SAMHD1
|
Health Risk |
Pathogenic |
Aicardi-Goutieres syndrome 5, Aicardi-Goutieres syndrome 5 |
| RS2515236275 |
SAMHD1
|
Health Risk |
Pathogenic |
Aicardi-Goutieres syndrome 5, Aicardi-Goutieres syndrome 5 |
| RS2515236292 |
SAMHD1
|
Health Risk |
Pathogenic |
Aicardi-Goutieres syndrome 5, Aicardi-Goutieres syndrome 5 |
| RS2515236840 |
SPTBN4
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with hypotonia, neuropathy |
| RS2515237951 |
SAMHD1
|
Health Risk |
Pathogenic |
Aicardi-Goutieres syndrome 5, Aicardi-Goutieres syndrome 5 |
| RS2515240742 |
PROKR2
|
Health Risk |
Pathogenic |
— |
| RS2515242437 |
KPTN
|
Health Risk |
Pathogenic |
Macrocephaly-developmental delay syndrome, Macrocephaly-developmental delay syndrome |
| RS2515244156 |
SAMHD1
|
Health Risk |
Pathogenic |
Aicardi-Goutieres syndrome 5, Aicardi-Goutieres syndrome 5 |
| RS2515244334 |
SAMHD1
|
Health Risk |
Pathogenic |
Aicardi-Goutieres syndrome 5, Aicardi-Goutieres syndrome 5 |
| RS2515244359 |
SAMHD1
|
Health Risk |
Likely pathogenic |
Aicardi-Goutieres syndrome 5, Aicardi-Goutieres syndrome 5 |
| RS2515244609 |
SAMHD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Aicardi-Goutieres syndrome 5, Chilblain lupus 2 |
| RS2515244774 |
SAMHD1
|
Health Risk |
Pathogenic |
Aicardi-Goutieres syndrome 5, Aicardi-Goutieres syndrome 5 |
| RS2515247150 |
PLCB1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 12 |
| RS2515247402 |
SAMHD1
|
Health Risk |
Pathogenic |
Aicardi-Goutieres syndrome 5, Aicardi-Goutieres syndrome 5 |
| RS2515254153 |
SAMHD1
|
Health Risk |
Likely pathogenic |
Aicardi-Goutieres syndrome 5, Aicardi-Goutieres syndrome 5 |
| RS2515258417 |
SAMHD1
|
Health Risk |
Likely pathogenic |
SAMHD1-related disorder, SAMHD1-related disorder |
| RS2515264064 |
SAMHD1
|
Health Risk |
Pathogenic |
Aicardi-Goutieres syndrome 5, Aicardi-Goutieres syndrome 5 |
| RS2515264339 |
SAMHD1
|
Health Risk |
Pathogenic |
Aicardi-Goutieres syndrome 5, Aicardi-Goutieres syndrome 5 |
| RS2515264387 |
SAMHD1
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Aicardi-Goutieres syndrome 5 |
| RS2515272357 |
SAMHD1
|
Health Risk |
Pathogenic |
Aicardi-Goutieres syndrome 5, Aicardi-Goutieres syndrome 5 |
| RS2515277441 |
PLCB1
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 12 |
| RS2515280406 |
SMARCA4
|
Health Risk |
Pathogenic |
Rhabdoid tumor predisposition syndrome 2, Rhabdoid tumor predisposition syndrome 2 |
| RS2515281114 |
PLCB1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 12 |
| RS2515285700 |
SMARCA4
|
Health Risk |
Pathogenic |
Rhabdoid tumor predisposition syndrome 2, Rhabdoid tumor predisposition syndrome 2 |
| RS2515286035 |
SAMHD1
|
Health Risk |
Pathogenic/Likely pathogenic |
SAMHD1-related disorder, Aicardi-Goutieres syndrome 5 |
| RS2515286349 |
SAMHD1
|
Health Risk |
Pathogenic |
Aicardi-Goutieres syndrome 5, Aicardi-Goutieres syndrome 5 |
| RS2515286894 |
PLCB1
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 12 |
| RS2515299378 |
PLCB1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 12 |
| RS2515320719 |
SMARCA4
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Rhabdoid tumor predisposition syndrome 2 |
| RS2515326219 |
PLCB1
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 12 |
| RS2515343230 |
CST3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cerebral amyloid angiopathy, Icelandic type |
| RS2515347436 |
PLCB1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 12 |
| RS2515347595 |
LTBP4
|
Health Risk |
Pathogenic |
— |
| RS2515347783 |
SMARCA4
|
Health Risk |
Pathogenic |
Rhabdoid tumor predisposition syndrome 2, Rhabdoid tumor predisposition syndrome 2 |
| RS2515349166 |
SMARCA4
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2515355393 |
IL12RB1
|
Health Risk |
Pathogenic |
Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency, Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency |
| RS2515356007 |
SMARCA4
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2515356493 |
LTBP4
|
Health Risk |
Likely pathogenic |
— |
| RS2515358792 |
LTBP4
|
Health Risk |
Likely pathogenic |
— |
| RS2515360019 |
LTBP4
|
Health Risk |
Likely pathogenic |
— |
| RS2515360712 |
LTBP4
|
Health Risk |
Pathogenic |
— |
| RS2515374018 |
LTBP4
|
Health Risk |
Pathogenic |
— |
| RS2515377150 |
LTBP4
|
Health Risk |
Conflicting classifications of pathogenicity |
LTBP4-related disorder, Inborn genetic diseases |
| RS2515377377 |
LTBP4
|
Health Risk |
Conflicting classifications of pathogenicity |
LTBP4-related disorder, Inborn genetic diseases |
| RS2515384166 |
LTBP4
|
Health Risk |
Pathogenic |
— |
| RS2515386007 |
LTBP4
|
Health Risk |
Likely pathogenic |
— |